Search CORE

51 research outputs found

Protocol of a randomized controlled trial of an erythropoietin stimulating agent decision aid for anemia treatment in kidney disease

Author: A Coulter
AG Bot
AJ Collins
AM O’Connor
AM O’Connor
AM O’Connor
AM O’Connor
BJ Manns
D Cella
DS Tuot
FDA Drug Safety Communication
G Elwyn
G Gigerenzer
G Makoul
Gowri Ramachandran
H. Omer Ikizler
J Wright Nunes
JA Wright
JC Brehaut
K Cavanaugh
Kerri L. Cavanaugh
KJ McCaffery
KL Cavanaugh
LA Dageforde
Lauren B. Beach
LM Schwartz
Marcus Wild
N Joseph-Williams
PA Ubel
RC Maly
S Borson
WC Winkelmayer
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Regional variation in antibiotic prescribing among medicare part D enrollees, 2013

Author: Andre Arizpe
B Spellberg
C Costelloe
C MacDougall
Centers for Disease Control and Prevention
CM Faulkner
DM Drekonja
EM Mortensen
FDA Drug Safety Communication
JD Alpern
JL Schroeck
KE Fleming-Dutra
Kelly R. Reveles
LA Hicks
M Alsan
M Lopez-Dupla
MA Steinman
MS Houston
R Stahlmann
RC Owens Jr
Samuel L. Aitken
WA Ray
Y Zhang
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Potential statin-drug interactions: prevalence and clinical significance

Author: A Bakhai
A Marot
AA Alsheikh-Ali
AE Rätz Bravo
AH Andreasen
AJ Lee
CA Jankel
CY Yu
D Herman
D Williams
E Grau
E Molden
FDA Drug Safety Communication
H Schelleman
J Ansell
JJ Lewin
JM McKenney
JR Horn
L Becquemont
L Roten
LH Cohen
M Beinema
M Hu
M Ucar
MA Omar
MB Bottorff
MERCK SHARP & DOHME LTD
MR Andrus
N Kanathur
P Gladding
P Stang
RM van Schie
S Bellosta
S Mondillo
SG Simonson
SS Egger
T Kantola
T Sakaeda
T Schalekamp
T Tirkkonen
T Westergren
TR Einarson
X Delavenne
Y Shitara
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance

Predictors of anemia in a multi-ethnic chronic kidney disease population: a case–control study

Author: AK Singh
BC Astor
CY Hsu
DA Revicki
DS Silverberg
DT Gilbertson
E Moore
F Moreno
F Moreno
F Valderrabano
FDA Drug Safety Communication
G Vink
HL Choong
I Wittwer
IR White
J Coresh
J Ly
J Portolés
J Rossert
JL Cresanta
JL Pickett
JN Basile
K Iseki
KDIGO Anemia Work Group
KDIGO Work Group
MA Pfeffer
Ministry of Health Singapore
National Kidney Foundation
P Ruggenenti
R London
RA Incalzi
S Al-Khoury
S Fishbane
S Nurko
SD Denny
SI McFarlane
SM Kim
T Hayashi
TB Drüeke
V Ramanath
W McClellan
WH Pan
Publication venue: 'Springer Science and Business Media LLC'
Publication date
Field of study

Role of combination therapy or coformulation products in treatment of type 2 diabetes

Novel Anticoagulants Eliminate the Need for Left Atrial Appendage Exclusion Devices

Author: FDA drug safety communication
Ruff CT
Publication venue: 'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study

News Flash: Old Mother Hubbard Reports the Cupboard is Bare… Time for the FDA to Let Droperidol Out of the (Black) Box

Author: FDA Drug Safety Communication
Niska R
Publication venue: 'SAGE Publications'
Publication date
Field of study

Proton Pump Inhibitors and Hypomagnesemia in Polymorbid Elderly Adults

Author: Ahrens
Arinzon
Batuwitage
Danziger
FDA Drug Safety Communication
Gau
Isaia
Isaia
Jarchow-MacDonald
Martin
Publication venue: 'Wiley'
Publication date
Field of study

Reply to Hardalo et al., “Myelosuppression with Oxazolidinones: Are There Differences?”

Author: Carr T
FDA Drug Safety Communication
Food and Drug Administration
Hill AB
Jadad AR
Strom BL
U.S. Food & Drug Administration
Publication venue: 'American Society for Microbiology'
Publication date
Field of study

…

core

core